Analyst Rating Update on Halyard Health (HYH)

Halyard Health (HYH) : 3 brokerage houses believe that Halyard Health (HYH) is a Strong Buy at current levels. 2 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Halyard Health (HYH). Zacks Investment Research suggests a Buy with a rank of 2. 1 others believe that the stock has run up ahead of its fundamentals and advise a Strong Sell on the stock.The median of all the 6 Wall Street Analysts endorse the stock as a Buy with a rating of 2.22.

Halyard Health (HYH) : Average target price received by Halyard Health (HYH) is $33.67 with an expected standard deviation of $4.93. The most aggressive target on the stock is $37, whereas the most downbeat target is $28. 3 financial analysts are currently covering the stock.

For the current week, the company shares have a recommendation consensus of Buy.


Halyard Health (NYSE:HYH): During Wednesdays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $35.12 and $34.28 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $36.21. The buying momentum continued till the end and the stock did not give up its gains. It closed at $34.77, notching a gain of 2.75% for the day. The total traded volume was 1,281,652 . The stock had closed at $33.84 on the previous day.

Halyard Health, Inc. seeks to advance health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company has two business segments: Surgical and Infection Prevention (S&IP) and Medical Devices. The Companys S&IP business provides healthcare supplies and solutions that target the prevention of healthcare associated infections. S&IPs product portfolio includes sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves. Medical Devices segment provides a portfolio of product offerings, including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems and enteral feeding tubes, focused on pain management and respiratory and digestive health.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.